Jan Boström

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression

Ruthild G. Weber, Jan Boström, Marietta Wolter et al. · Proceedings of the National Academy of Sciences · 1997 · 411 citations

Life Sciences, Genetics, Oncology +14

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Michael Weller, Ruthild G. Weber, Edith Willscher et al. · Acta Neuropathologica · 2015 · 316 citations · Full text

Medicine, Cancer Biology, Oncology +17

Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic Meningiomas

Jan Boström, Birgit Meyer‐Puttlitz, Marietta Wolter et al. · American Journal Of Pathology · 2001 · 274 citations · Full text

Medicine, Genetics, Oncology +12

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

Markus J. Riemenschneider, Rainer Büschges, Marietta Wolter et al. · PubMed · 1999 · 249 citations

Medicine, Molecular Genetics, Oncology +14

Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

Jan Boström, J. M. J. Ludwig Cobbers, Marietta Wolter et al. · PubMed · 1998 · 198 citations

Medicine, Genetics, Oncology +16